142 related articles for article (PubMed ID: 12032391)
21. Use of the PFA-100 closure time to predict cardiovascular events in aspirin-treated cardiovascular patients: a systematic review and meta-analysis.
Reny JL; De Moerloose P; Dauzat M; Fontana P
J Thromb Haemost; 2008 Mar; 6(3):444-50. PubMed ID: 18194417
[TBL] [Abstract][Full Text] [Related]
22. PFA-100 System: A New Method for Assessment of Platelet Dysfunction.
Mammen EF; Comp PC; Gosselin R; Greenberg C; Hoots WK; Kessler CM; Larkin EC; Liles D; Nugent DJ
Semin Thromb Hemost; 2024 Jun; 50(4):664-671. PubMed ID: 38092024
[TBL] [Abstract][Full Text] [Related]
23. [Use of platelet function analyzer PFA-100 and whole blood aggregometry to monitor blood platelet sensitivity to acetylsalicylic acid (aspirin). Is it possible to reliably monitor antiplatelet treatment using routine laboratory diagnostic methods?].
Golański J; Chizyński K; Golański R; Watała C
Pol Arch Med Wewn; 2000 Jul; 104(1):355-61. PubMed ID: 11303325
[TBL] [Abstract][Full Text] [Related]
24. Impaired platelet function among platelet donors.
Jilma-Stohlawetz P; Hergovich N; Homoncik M; Dzirlo L; Horvath M; Janisiw M; Panzer S; Jilma B
Thromb Haemost; 2001 Sep; 86(3):880-6. PubMed ID: 11583322
[TBL] [Abstract][Full Text] [Related]
25. Relation between impaired antiplatelet response to clopidogrel and possible pleiotropic effects.
Malek LA; Grabowski M; Spiewak M; Filipiak KJ; Szpotanska M; Imiela T; Huczek Z; Bobilewicz D; Opolski G
J Thromb Thrombolysis; 2007 Dec; 24(3):301-5. PubMed ID: 17404690
[TBL] [Abstract][Full Text] [Related]
26. Assessment of the antiplatelet effects of low to medium dose aspirin in the early and late phases after ischaemic stroke and TIA.
McCabe DJ; Harrison P; Mackie IJ; Sidhu PS; Lawrie AS; Purdy G; Machin SJ; Brown MM
Platelets; 2005 Aug; 16(5):269-80. PubMed ID: 16011977
[TBL] [Abstract][Full Text] [Related]
27. Utility of the PFA-100 instrument and the novel multiplate analyzer for the assessment of aspirin and clopidogrel effects on platelet function in patients with cardiovascular disease.
Mueller T; Dieplinger B; Poelz W; Haltmayer M
Clin Appl Thromb Hemost; 2009 Dec; 15(6):652-9. PubMed ID: 18805846
[TBL] [Abstract][Full Text] [Related]
28. Assessment of Aspirin and Clopidogrel Resistance in Patients Undergoing Cardiovascular Surgery: A Single-Center Cross-Sectional Study.
Özer A; Demirtaş H; Tak S; Koçak B; Yiğiter EN; Oktar GL; Kaya Z
Turk J Haematol; 2024 May; 41(2):105-112. PubMed ID: 38501691
[TBL] [Abstract][Full Text] [Related]
29. Reduced sensitivity of platelets from type 2 diabetic patients to acetylsalicylic acid (aspirin)-its relation to metabolic control.
Watala C; Golanski J; Pluta J; Boncler M; Rozalski M; Luzak B; Kropiwnicka A; Drzewoski J
Thromb Res; 2004; 113(2):101-13. PubMed ID: 15115665
[TBL] [Abstract][Full Text] [Related]
30. In vitro bleeding test with PFA-100-aspects of controlling individual acetylsalicylic acid induced platelet inhibition in patients with cardiovascular disease.
Peters AJ; Borries M; Gradaus F; Jax TW; Schoebel FC; Strauer BE
J Thromb Thrombolysis; 2001 Dec; 12(3):263-72. PubMed ID: 11981109
[TBL] [Abstract][Full Text] [Related]
31. Platelet hyper-function in acute coronary syndromes.
Harrison P; Mackie I; Mathur A; Robinson MS; Hong Y; Erusalimsky JD; Machin SJ; Martin JF
Blood Coagul Fibrinolysis; 2005 Nov; 16(8):557-62. PubMed ID: 16269928
[TBL] [Abstract][Full Text] [Related]
32. Variables that Influence Platelet Function Analyzer-100™ Closure Times in Healthy Algerian Adults.
Belkacemi M; Merad Y
Int J Appl Basic Med Res; 2021; 11(3):154-159. PubMed ID: 34458117
[TBL] [Abstract][Full Text] [Related]
33. Direct evidence for normalization of platelet function resulting from platelet count reduction in essential thrombocythemia.
Tsantes AE; Nikolopoulos GK; Tsirigotis P; Zoi K; Zomas A; Kapsimali V; Kopterides P; Chondropoulos S; Dervenoulas J; Mantzios G
Blood Coagul Fibrinolysis; 2011 Sep; 22(6):457-62. PubMed ID: 21836466
[TBL] [Abstract][Full Text] [Related]
34. Persistent platelet activation is related to very early cardiovascular events in patients with acute coronary syndromes.
Małek ŁA; Spiewak M; Filipiak KJ; Grabowski M; Szpotańska M; Rosiak M; Główczyńska R; Imiela T; Huczek Z; Opolski G
Kardiol Pol; 2007 Jan; 65(1):40-5; discussion 46. PubMed ID: 17295159
[TBL] [Abstract][Full Text] [Related]
35. Variability and persistence of aspirin response in lower extremity peripheral arterial disease patients.
Saunders J; Nambi V; Kimball KT; Virani SS; Morrisett JD; Lumsden AB; Ballantyne CM; Dong JF;
J Vasc Surg; 2011 Mar; 53(3):668-75. PubMed ID: 21227624
[TBL] [Abstract][Full Text] [Related]
36. Factors responsible for "aspirin resistance" - can we identify them?
Postuła M; Tarchalska-Kryńska B; Filipiak KJ; Kosior D; Serafin A; Huczek Z; Opolski G
Kardiol Pol; 2010 Apr; 68(4):403-11; discussion 412-3. PubMed ID: 20425699
[TBL] [Abstract][Full Text] [Related]
37. Use of a novel platelet function analyzer (PFA-100) with high sensitivity to disturbances in von Willebrand factor to screen for von Willebrand's disease and other disorders.
Favaloro EJ; Facey D; Henniker A
Am J Hematol; 1999 Nov; 62(3):165-74. PubMed ID: 10539883
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of a Platelet Function Analyser (PFA-100) in patients with a bleeding tendency.
Wuillemin WA; Gasser Ka; Zeerleder SS; Lämmle B
Swiss Med Wkly; 2002 Aug; 132(31-32):443-8. PubMed ID: 12457302
[TBL] [Abstract][Full Text] [Related]
39. The PFA-100: a potential rapid screening tool for the assessment of platelet dysfunction.
Harrison P; Robinson M; Liesner R; Khair K; Cohen H; Mackie I; Machin S
Clin Lab Haematol; 2002 Aug; 24(4):225-32. PubMed ID: 12181026
[TBL] [Abstract][Full Text] [Related]
40. Aspirin non-responsiveness in Korean subjects on dual anti-platelet treatment determined by two different platelet function assays.
Lee YW; Cho YH; Kim YH; Na JS; Shin HB; Ki CS; Choi TY; Lee YK
Ann Clin Lab Sci; 2008; 38(2):126-31. PubMed ID: 18469357
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
